Related Experiment Video
Updated: Sep 9, 2025
10:04
Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
Published on: December 2, 2022
4.7K
Shining light on liquid-liquid phase separation in chronic liver disease
Ming-Hui Li1, Yang Yang2, Qi-Qi Dong1
1Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China; School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Drug Discovery Today
|September 4, 2025
Summary
Liquid-liquid phase separation (LLPS) is crucial in chronic liver diseases, impacting viral replication, metabolism, immunity, and gene expression. Understanding LLPS mechanisms offers new therapeutic strategies for liver disease treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Hepatology
Background:
- Liquid-liquid phase separation (LLPS) involves the formation of membrane-less intracellular structures through weak multivalent interactions of biomacromolecules.
- LLPS is increasingly recognized for its significant roles in the pathogenesis of chronic liver diseases.
Purpose of the Study:
- To review the specific mechanisms by which LLPS influences the occurrence and progression of chronic liver diseases.
- To explore the potential applications of targeting LLPS in the development of novel therapeutic strategies for chronic liver diseases.
Main Methods:
- Literature review and synthesis of existing research on LLPS in the context of liver disease.
- Analysis of the molecular mechanisms underlying LLPS involvement in key pathological processes of chronic liver disease.
Main Results:
- LLPS modulates critical cellular processes including viral replication, lipid metabolism, immune responses, and gene expression within the liver.
- Dysregulation of LLPS contributes to the development and advancement of chronic liver conditions.
Conclusions:
- Targeting LLPS presents promising avenues for innovative drug development, immunotherapy, and gene therapy in treating chronic liver diseases.
- Further research into LLPS mechanisms can provide novel insights and therapeutic targets for liver disease management.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
957
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
957
01:24Chronic Pancreatitis I: Introduction
147
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
147